Skip to main content

Jetrea Side Effects

Generic name: ocriplasmin ophthalmic

Medically reviewed by Drugs.com. Last updated on Jan 1, 2025.

Note: This document provides detailed information about Jetrea.

Applies to ocriplasmin ophthalmic: parenteral injection Side Effects associated with ocriplasmin ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Jetrea.

Applies to ocriplasmin ophthalmic: parenteral injection.

Side effects include:

Vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema.

For healthcare professionals

Applies to ocriplasmin ophthalmic: intravitreal solution.

General adverse events

The most commonly reported side effects included vitreous floaters, eye pain, photopsia, and blurred vision.[Ref]

Ocular

Nervous system

Local

Immunologic

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics."

2. Cerner Multum, Inc. "Australian Product Information."

3. (2012) "Product Information. Jetrea (ocriplasmin ophthalmic)." ThromboGenics Inc

Further information

Jetrea side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.